The trajectory of companies tied to Sildenafil's history presents a challenging investment scenario . While the initial surge generated substantial profits , generic alternatives have significantly impacted market share . Investing in connected pharmaceutical businesses now requires a thorough assessment of patent rights , evolving healthcare chang